Document is current
Any future updates will be listed below
-
Authors
Chen, Yanxin
Wu, Zhengjun
Wang, Lingyan
Lin, Minhui
Jiang, Peifang
Wen, Jingjing
Li, Jiazheng
Hong, Yunda
Zheng, Xiaoyun
Yang, Xiaozhu
Zheng, Jing
Gale, Robert Peter
Yang, Ting
Hu, Jianda
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2020J05049)
National Natural Science Foundation of China (82000142, 81870135, 81470326, U2005204)
Joint Funds for the innovation of science and Technology，Fujian province (2021Y9086)
- License Information
-
More Information
Article History
Accepted: 7 June 2023
First Online: 24 July 2023
Declarations
:
: All the experiments were approved by the review board of the Ethics Committee and the Institutional Review Board of Fujian Medical University Union Hospital (2014058). All animal experiments were approved by the Ethics Committee of Institutional Animal Care and Use. BALB/C nude mice and NCG mice experiments were carried out following the guidelines of the animal facility at Fujian Medical University. NSI mice experiments were carried out following the guidelines of the animal facility in the Laboratory Animal Center of the Guangzhou Institutes of Biomedicine and Health (GIBH). All patients gave written informed consent to use their clinical specimens for medical research.
: Written informed consent for publication was obtained from the patients. All authors have agreed to publish this manuscript.
: RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc., and CStone Pharmaceuticals; advisor to Antegene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.
